Watchlist Price Alert

Voyager Therapeutics Inc. (VYGR)

NASDAQ: VYGR · Real-Time Price · USD

3.08

-0.07 (-2.22%)

At close: May 22, 2025, 11:05 AM

Voyager Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	80M	250.01M	40.91M	37.41M	171.13M	104.39M	7.62M	10.13M	14.22M
Cost of Revenue	n/a	4.44M	6.19M	73.79M	108.75M	119.73M	64.91M	62.26M	42.25M
Gross Profit	75.27M	245.57M	34.72M	-36.37M	62.38M	-15.34M	-57.29M	-52.13M	-28.03M
Operating Income	-83.29M	122.01M	-50.84M	-73.62M	27.38M	-51.68M	-91.09M	-71.86M	-41.3M
Interest Income	18.33M	11.72M	1.79M	390K	1.66M	6.46M	n/a	1.23M	n/a
Pretax Income	-64.34M	133.74M	-46.39M	-71.2M	36.74M	-43.6M	-88.47M	-70.7M	-40.14M
Net Income	-65M	132.33M	-46.41M	-66.03M	36.74M	-40.83M	-88.29M	-70.7M	-40.19M
Selling & General & Admin	35.92M	35.82M	30.98M	37.25M	34.99M	36.34M	33.81M	19.74M	13.27M
Research & Development	127.37M	92.17M	60.76M	73.79M	108.75M	119.73M	64.91M	62.26M	42.25M
Other Expenses	n/a	n/a	4.45M	2.42M	7.7M	8.08M	2.63M	1.17M	1.16M
Operating Expenses	163.29M	127.99M	91.74M	111.03M	143.74M	156.07M	98.71M	82M	55.52M
Interest Expense	n/a	n/a	1.79M	n/a	n/a	n/a	n/a	n/a	976K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	163.29M	127.99M	91.74M	111.03M	143.74M	156.07M	98.71M	82M	55.52M
Income Tax Expense	665K	1.41M	16K	-5.17M	-1.66M	-2.77M	-180K	-1.59M	52K
Shares Outstanding (Basic)	57.67M	43.02M	38.36M	37.67M	37.13M	35.9M	32.07M	26.8M	25.3M
Shares Outstanding (Diluted)	57.67M	44.57M	38.36M	37.67M	37.35M	35.9M	32.07M	26.8M	25.3M
EPS (Basic)	-1.13	3.08	-1.21	-1.75	0.99	-1.14	-2.75	-2.64	-1.59
EPS (Diluted)	-1.13	2.97	-1.21	-1.75	0.98	-1.14	-2.75	-2.64	-1.59
EBITDA	-83.29M	126.45M	-44.65M	-68.45M	31.2M	-48.91M	-88.98M	-70.27M	-40.69M
EBIT	-83.29M	122.01M	-50.84M	-73.62M	36.74M	-51.68M	-91.09M	-71.86M	-41.3M
Depreciation & Amortization	n/a	4.44M	6.19M	5.17M	3.82M	2.77M	2.12M	1.59M	612K